SP
Symmetry Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
2,942
+79
| +3% | +$14.7K | 0.07% | 84 |
|
|
2025
Q1 | $600K | Buy |
2,863
+1,032
| +56% | +$216K | 0.08% | 79 |
|
|
2024
Q4 | $325K | Buy |
1,831
+524
| +40% | +$93.1K | 0.05% | 94 |
|
|
2024
Q3 | $258K | Sell |
1,307
-13,207
| -91% | -$2.61M | 0.06% | 75 |
|
|
2024
Q2 | $2.49M | Sell |
14,514
-2,093
| -13% | -$359K | 0.13% | 69 |
|
|
2024
Q1 | $3.02M | Sell |
16,607
-1,081
| -6% | -$197K | 0.24% | 59 |
|
|
2023
Q4 | $2.74M | Sell |
17,688
-243
| -1% | -$37.6K | 0.15% | 68 |
|
|
2023
Q3 | $2.67M | Sell |
17,931
-5,164
| -22% | -$770K | 0.14% | 72 |
|
|
2023
Q2 | $3.11M | Sell |
23,095
-14,508
| -39% | -$1.95M | 0.16% | 71 |
|
|
2023
Q1 | $5.99M | Buy |
37,603
+557
| +2% | +$88.8K | 0.33% | 49 |
|
|
2022
Q4 | $5.99M | Sell |
37,046
-2,872
| -7% | -$464K | 0.35% | 46 |
|
|
2022
Q3 | $5.36M | Buy |
39,918
+10,920
| +38% | +$1.47M | 0.36% | 47 |
|
|
2022
Q2 | $4.44M | Sell |
28,998
-6,237
| -18% | -$955K | 0.3% | 47 |
|
|
2022
Q1 | $5.71M | Buy |
35,235
+6,142
| +21% | +$996K | 0.36% | 42 |
|
|
2021
Q4 | $3.94M | Buy |
29,093
+635
| +2% | +$86K | 0.25% | 52 |
|
|
2021
Q3 | $3.12M | Sell |
28,458
-800
| -3% | -$87.6K | 0.21% | 65 |
|
|
2021
Q2 | $3.3M | Sell |
29,258
-9,422
| -24% | -$1.06M | 0.22% | 73 |
|
|
2021
Q1 | $4.19M | Buy |
38,680
+254
| +0.7% | +$27.5K | 0.3% | 58 |
|
|
2020
Q4 | $4.12M | Sell |
38,426
-4,547
| -11% | -$487K | 0.32% | 49 |
|
|
2020
Q3 | $3.76M | Buy |
42,973
+23,346
| +119% | +$2.04M | 0.32% | 50 |
|
|
2020
Q2 | $1.93M | Buy |
19,627
+15,775
| +410% | +$1.55M | 0.24% | 56 |
|
|
2020
Q1 | $293K | Buy |
+3,852
| New | +$293K | 0.07% | 212 |
|